Guobang Pharma Ltd.
605507.SS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.01B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $12.01 Billion |
|---|---|
| Enterprise Value | $12.81 Billion |
| Annual dividend | $0.60 |
| Dividend yield | 3.91% |
| Earnings per Share | $1.48 |
| Beta | 0.22 |
| Outstanding Shares | 770,980,784 |
Return
| Return on Equity | 7.40% |
|---|---|
| Return on Assets | 5.46% |
| Return on Invested Capital | 8.69% |
Valuation & Multiples
| P/E Ratio | 15.82 |
|---|---|
| PEG | -40.13 |
| Price to Sales | 2.17 |
| Price to Book Ratio | 1.52 |
| Enterprise Value to Revenue | 2.09 |
| Enterprise Value to EBIT | 17.09 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 24, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
April 12, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Guobang Pharma Ltd.
4,251 employees
CEO: Shixue Liao
Guobang Pharma Ltd., a Chinese company, specializes in the research, development, manufacturing, and distribution of pharmaceutical products for both human and veterinary use within China. For human healthcare, their offerings encompass ...